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Dear Editor,
The World Health Organization (WHO) has declared rapid
infection of the severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) across the globe as a pandemic
onMarch 11, 2020. Although the main mode of SARS-CoV-2
transmission is predominantly respiratory, several studies
have suggested that exposure of unprotected eyes to the virus
may also cause novel coronavirus pneumonia (NCP) [1, 2]. In
agreement, a recent animal study also confirmed that ma-
caque’s conjunctiva inoculated with SARS-CoV-2 lead to
the development of mild interstitial pneumonia [3], implying
that ocular tissues and fluid may be a potential alternative
mode of SARS-CoV-2 transmission. So far, there have been
varying reports regarding the prevalence of ocular manifesta-
tions among COVID-19-infected patients [2, 4–9]. Hence, in
order to summarize the current evidence, a meta-analysis was
conducted to estimate the prevalence of ocular manifestations
among COVID-19-infected patients. In addition, the diagnos-
tic value of ocular tissue/fluid in detecting SARS-CoV-2 was
also evaluated.
A comprehensive literature search was conducted from
PubMed, Scopus, Web of Science, and Google scholar.
Keywords such as “ocular/eye/ophthalmology,” “coronavirus
2019/COVID-19,” “2019-nCoV,” and “SARS-CoV-2” were
used singularly or in combination without applying language
restriction and dated up to April 4, 2020. Criteria of studies
included in this meta-analysis were (1) observational studies that
reported ocular symptoms among COVID-19-infected patients
and (2) comparing diagnostic outcomes between ocular tissue
and fluid (conjunctival swab/tears) and nasopharyngeal swab or
sputum in detecting SARS-CoV-2 by polymerase chain reaction
(PCR) analysis. Seven studies were included in this meta-
analysis [2, 4–9]. Prevalence estimates of ocular manifestations
were calculated from six studies [2, 4, 5, 7–9] (Table 1).
Heterogeneity was evaluated with the I2 statistic, in which an
I2 value over 50% was considered an indicator of substantial
heterogeneity. If heterogeneity existed, the random-effectsmodel
was then used; otherwise, the fixed-effects model was applied. A
funnel plot and Begg’s test were used to investigate the publica-
tion bias if the pooled effect size consisted of 10 or more studies.
The value of 0.05 was indicative of the statistical significance.
The prevalence of ocular manifestations among COVID-
19-infected patients ranged from 2 to 32%. The random-
effects model was used due to heterogeneity (I2 = 69.62%,
p = 0.006). The overall pooled prevalence of ocular manifes-
tations among COVID-19-infected patients was 5.5% (42/735
subjects, 95% CI 1.6–9.4%; Fig. 1). The pooled sensitivity
and specificity were calculated from six studies [2, 4–7, 9].
Although the pooled specificity was high (100%, 95% CI 0–
100), the pooled sensitivity of ocular tissue/fluid in detecting
SARS-CoV-2 was very low (0.6%, 95% CI 0.1–5.1) in com-
parison with standard sample collection from nasopharyngeal
swab/sputum (Table 1).
Therefore, in this current analysis, we emphasize that ocu-
lar symptoms have relatively low prevalence among COVID-
19-infected patients. Interestingly, it seems that the ophthalmic
manifestations appear to be associated with the disease sever-
ity of COVID-19 [5, 8]. And although ocular tissue/fluid is
useable for SARS-CoV-2 detection, the procedure may not be
useful for diagnostic purposes in the clinical setting. Despite
the findings, ocular transmission of SARS-CoV-2 remains a
crucial issue that requires vigilance of protecting the ocular
surface and by wearing protective equipment during ophthal-
mic examination and handling of ocular fluids by the physi-
cian or health care worker.
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Table 1 Characteristics of included study in this meta-analysis
Study Location No. of cases Women (%) Age Ocular symptoms PCR SARS-CoV-2
Yes No CS/tears NP/sputum
Chen et al. [8] China 534 NR 40/50 (mean) 25 509 NR 371
Deng et al. [6] China 114 54 61.4 (mean) NR 114 0 90
Jun et al. [4] Singapore 17 NR NR 1 16 0 17
Wu et al. [5] China 38 34 68 (median) 12 26 2 11
Xia et al. [7] China 30 30 54.5 (mean) 1 29 0 29
Xu et al. [9] China 14 50 48 (mean) 1 13 0 14
Zhang et al. [2] China 102 50 57.63 (mean) 2 100 1 72
CS, conjunctival swab; NP, nasopharyngeal swab; NR, not reported; PCR, polymerase chain reaction
Fig. 1 Forest plot of the 6 studies estimating the pooled prevalence of ocular manifestations among COVID-19-infected patients
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